Setting Research Priorities to Reduce Mortality and Morbidity of Childhood Diarrhoeal Disease in the Next 15 Years

Kerri Wazny; Alvin Zipursky; Robert Black; Valerie Curtis; Christopher Duggan; Richard Guerrant; Myron Levine; William A. Petri; Mathuram Santosham; Rebecca Scharf; Philip M. Sherman; Evan Simpson; Mark Young; Zulfiqar A. Bhutta

doi:10.1371/journal.pmed.1001446

Setting Research Priorities to Reduce Mortality and Morbidity of Childhood Diarrhoeal Disease in the Next 15 Years

Kerri Wazny, Alvin Zipursky, Robert Black, Valerie Curtis, Christopher Duggan, Richard Guerrant, Myron Levine, William A. Petri, Mathuram Santosham, Rebecca Scharf, Philip M. Sherman, Evan Simpson, Mark Young, Zulfiqar A. Bhutta

Institute for Global Health and Development, Pakistan

Research output: Contribution to journal › Article › peer-review

37 Citations (Scopus)

Original language	English
Article number	e1001446
Journal	PLoS Medicine
Volume	10
Issue number	5
DOIs	https://doi.org/10.1371/journal.pmed.1001446
Publication status	Published - 2013

Access to Document

10.1371/journal.pmed.1001446

Cite this

Wazny, K., Zipursky, A., Black, R., Curtis, V., Duggan, C., Guerrant, R., Levine, M., Petri, W. A., Santosham, M., Scharf, R., Sherman, P. M., Simpson, E., Young, M., & Bhutta, Z. A. (2013). Setting Research Priorities to Reduce Mortality and Morbidity of Childhood Diarrhoeal Disease in the Next 15 Years. PLoS Medicine, 10(5), Article e1001446. https://doi.org/10.1371/journal.pmed.1001446

@article{8906ba23cee244f0b284fd37a86954be,

title = "Setting Research Priorities to Reduce Mortality and Morbidity of Childhood Diarrhoeal Disease in the Next 15 Years",

author = "Kerri Wazny and Alvin Zipursky and Robert Black and Valerie Curtis and Christopher Duggan and Richard Guerrant and Myron Levine and Petri, {William A.} and Mathuram Santosham and Rebecca Scharf and Sherman, {Philip M.} and Evan Simpson and Mark Young and Bhutta, {Zulfiqar A.}",

note = "Funding Information: VC is the principal investigator on a research grant from Unilever Plc that aims to understand behaviour associated with handwashing with soap. ML holds a patent as co-inventor of live oral cholera vaccine strain CVD 103-HgR, which has been licensed by the vaccine company PaxVax, who are supporting the clinical development program towards national regulatory agency licensure of the vaccine. MS is on the editorial board of PLOS Medicine. PMS sits on the Medical Scientific Advisory Board for Alberta Inflammatory Bowel Disease Research Consortium. PMS sits on Medical Advisory Boards for Abbott Nutrition, Mead Johnson Nutrition, and Proctor and Gamble; PMS sits on the Research Advisory Board for Antibe Therapeutics and is a stockholder. PMS also currently holds a research contract from Institut Rosell-Lallemand Inc. (Montreal, Quebec, Canada) to study the effectiveness of a short-chain fructo-oligosaccharide (sc-FOS) prebiotic preparation in ameliorating intestinal epithelial injury in response to bacterial enteric pathogens using both polarized model epithelia in tissue culture and a murine model of colitis, undertaken in the Research Institute at the Hospital for Sick Children in Toronto, Canada where the funds are held in a research funding account. The studies are also supported by research funding from the Canadian Institutes of Health Research (2008–2013) and previously by a Fay Shapiro-Cutler grant-in-aid from the Crohn's and Colitis Foundation of Canada (2007–2010). ZAB is on the editorial board of PLOS Medicine, and is the principal investigator of the grant from the Bill & Melinda Gates Foundation to coordinate the development of the Global Action Plan for Pneumonia and Diarrhoea. All other authors report no competing interests. ",

year = "2013",

doi = "10.1371/journal.pmed.1001446",

language = "English",

volume = "10",

journal = "PLoS Medicine",

issn = "1549-1277",

publisher = "Public Library of Science",

number = "5",

}

Wazny, K, Zipursky, A, Black, R, Curtis, V, Duggan, C, Guerrant, R, Levine, M, Petri, WA, Santosham, M, Scharf, R, Sherman, PM, Simpson, E, Young, M & Bhutta, ZA 2013, 'Setting Research Priorities to Reduce Mortality and Morbidity of Childhood Diarrhoeal Disease in the Next 15 Years', PLoS Medicine, vol. 10, no. 5, e1001446. https://doi.org/10.1371/journal.pmed.1001446

TY - JOUR

T1 - Setting Research Priorities to Reduce Mortality and Morbidity of Childhood Diarrhoeal Disease in the Next 15 Years

AU - Wazny, Kerri

AU - Zipursky, Alvin

AU - Black, Robert

AU - Curtis, Valerie

AU - Duggan, Christopher

AU - Guerrant, Richard

AU - Levine, Myron

AU - Petri, William A.

AU - Santosham, Mathuram

AU - Scharf, Rebecca

AU - Sherman, Philip M.

AU - Simpson, Evan

AU - Young, Mark

AU - Bhutta, Zulfiqar A.

N1 - Funding Information: VC is the principal investigator on a research grant from Unilever Plc that aims to understand behaviour associated with handwashing with soap. ML holds a patent as co-inventor of live oral cholera vaccine strain CVD 103-HgR, which has been licensed by the vaccine company PaxVax, who are supporting the clinical development program towards national regulatory agency licensure of the vaccine. MS is on the editorial board of PLOS Medicine. PMS sits on the Medical Scientific Advisory Board for Alberta Inflammatory Bowel Disease Research Consortium. PMS sits on Medical Advisory Boards for Abbott Nutrition, Mead Johnson Nutrition, and Proctor and Gamble; PMS sits on the Research Advisory Board for Antibe Therapeutics and is a stockholder. PMS also currently holds a research contract from Institut Rosell-Lallemand Inc. (Montreal, Quebec, Canada) to study the effectiveness of a short-chain fructo-oligosaccharide (sc-FOS) prebiotic preparation in ameliorating intestinal epithelial injury in response to bacterial enteric pathogens using both polarized model epithelia in tissue culture and a murine model of colitis, undertaken in the Research Institute at the Hospital for Sick Children in Toronto, Canada where the funds are held in a research funding account. The studies are also supported by research funding from the Canadian Institutes of Health Research (2008–2013) and previously by a Fay Shapiro-Cutler grant-in-aid from the Crohn's and Colitis Foundation of Canada (2007–2010). ZAB is on the editorial board of PLOS Medicine, and is the principal investigator of the grant from the Bill & Melinda Gates Foundation to coordinate the development of the Global Action Plan for Pneumonia and Diarrhoea. All other authors report no competing interests.

PY - 2013

Y1 - 2013

UR - http://www.scopus.com/inward/record.url?scp=84878334364&partnerID=8YFLogxK

U2 - 10.1371/journal.pmed.1001446

DO - 10.1371/journal.pmed.1001446

M3 - Article

C2 - 23690756

AN - SCOPUS:84878334364

SN - 1549-1277

VL - 10

JO - PLoS Medicine

JF - PLoS Medicine

IS - 5

M1 - e1001446

ER -

Setting Research Priorities to Reduce Mortality and Morbidity of Childhood Diarrhoeal Disease in the Next 15 Years

Access to Document

Other files and links

Cite this